Kozak & Associates’s AB InBev BUD Stock Holding History

Kozak & Associates’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29	Closed	-$1.8K	–	433
2025 Q3	$1.8K	Buy	+29	New	+$1.82K	﹤0.01%	385
2023 Q4	–	Sell	-69	Closed	-$3.64K	–	375
2023 Q3	$3.64K	Buy	+69	New	+$3.91K	﹤0.01%	305

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Kozak & Associates's BUD Position: Q4 2025 in Review

Kozak & Associates sold out of AB InBev (BUD) in Q4 2025, closing a stake of 29 shares — an estimated $1.8K sold.

Kozak & Associates first reported a position in BUD in Q3 2023 and held it in 2 quarters. The position peaked at $3.64K in Q3 2023. 535 funds tracked by Wall St. Rank hold BUD as of Q4 2025.

Kozak & Associates reported no remaining AB InBev position as of Q4 2025 after selling out during the quarter.
Kozak & Associates sold 29 AB InBev shares in Q4 2025, an estimated $1.8K.
Kozak & Associates first reported a position in AB InBev in Q3 2023 and held it in 2 quarters.
Kozak & Associates's AB InBev position peaked at $3.64K in Q3 2023.
535 funds tracked by Wall St. Rank held AB InBev as of Q4 2025.

Based on Kozak & Associates's 13F filing for Q4 2025, filed 12 Jan 2026.